OBALON THERAPEUTICS INC 4
4 · OBALON THERAPEUTICS INC · Filed Nov 14, 2016
Insider Transaction Report
Form 4
Rasdal Andrew P
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2016-11-09+300,000→ 300,000 totalExercise: $8.74Exp: 2026-11-09→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The option vests as to 2.0833% of the total shares monthly, commencing on December 9, 2016, with 100% of the total shares vested on November 9, 2020, subject to the reporting person's provision of service to the issuer as the issuer's chief executive officer on each vesting date.